Ping An Biomedical Co., Ltd. PASW
Annual
Quarterly
FY2025 · ended Sep 30, 2025 · Revenue $4.80M · Filed Jan 30, 2026
Ping An Biomedical Co., Ltd. (PASW) files with the SEC under industry code 2300, Apparel & Other Finishd Prods of Fabrics & Similar Matl. In fiscal 2025, which ended Sep 30, 2025, it reported revenue of $4.8 million and a net loss of $1.8 million. As of Sep 30, 2025 it held $164,697 in cash and investments and $1.5 million in total debt.
Revenue
$4.80M
Net income
$-1.80M
Operating cash flow
$-902,902
Free cash flow
—
EPS
$-0.10
Dividend per share
None
Shares outstanding
20.50M
Net cash
$-1.31M
FY 2025
Operating margin
-43.1%
FY 2025
Company profile
- Industry
- Apparel & Other Finishd Prods of Fabrics & Similar Matl (SIC 2300)
- Listed as
- PASW (Nasdaq)
- Incorporated in
- Cayman Islands
- Headquarters
- Cheung Sha Wan, Kowloon
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1897532
- Former names
- Majestic Ideal Holdings Ltd (until Sep 29, 2025)
Other Apparel & Other Finishd Prods of Fabrics & Similar Matl companies
- Amer Sports, Inc. AS
- lululemon athletica inc. LULU
- Levi Strauss & Co LEVI
- Gildan Activewear Inc. GIL
- Ermenegildo Zegna N.V. ZGN
- Columbia Sportswear Co COLM
- FIGS, Inc. FIGS
- Under Armour, Inc. UAA
All 18 Apparel & Other Finishd Prods of Fabrics & Similar Matl companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Sep 30, 2025 |
|---|---|
| Revenue | $4.8M |
| Operating income | -$2.1M |
| Net income | -$1.8M |
| Diluted EPS | -$0.10 |
| Operating cash flow | -$902,902 |
| Total assets | $9.6M |
| Total liabilities | $3.3M |
| Stockholders' equity | $6.4M |
| Cash and investments | $164,697 |
| Total debt | $1.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 5, 2026 | Nov 5, 2026 |
| 6-K | Current report (foreign issuer) | Oct 30, 2026 | Oct 30, 2026 |
| 6-K | Current report (foreign issuer) | Oct 26, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 22, 2026 | Oct 22, 2026 |
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Sep 11, 2026 | Mar 31, 2026 |
All 110 Ping An Biomedical Co., Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.